Published in Cochrane Database Syst Rev on November 14, 2012
β-Blockers as initial therapy for hypertension. JAMA (2013) 2.00
Blood pressure control and primary prevention of stroke: summary of the recent clinical trial data and meta-analyses. Curr Hypertens Rep (2013) 0.88
Administration of a selective β2 adrenergic receptor antagonist exacerbates neuropathology and cognitive deficits in a mouse model of Alzheimer's disease. Neurobiol Aging (2014) 0.82
β-Blockers in hypertension, diabetes, heart failure and acute myocardial infarction: a review of the literature. Open Heart (2015) 0.81
Beta-blockers in heart failure with preserved ejection fraction: a meta-analysis. Heart Fail Rev (2015) 0.81
An assessment of randomized controlled trials (RCTs) for non-communicable diseases (NCDs): more and higher quality research is required in less developed countries. Sci Rep (2015) 0.80
Combination therapy of renin-angiotensin system inhibitors plus calcium channel blockers versus other two-drug combinations for hypertension: a systematic review and meta-analysis. J Hum Hypertens (2016) 0.79
A two-for-one bargain: using cilnidipine to treat hypertension and its comorbidities. J Clin Hypertens (Greenwich) (2013) 0.79
Increasing complexity: which drug class to choose for treatment of hypertension in the elderly? Clin Interv Aging (2014) 0.79
Single Agent Antihypertensive Therapy and Orthostatic Blood Pressure Behaviour in Older Adults Using Beat-to-Beat Measurements: The Irish Longitudinal Study on Ageing. PLoS One (2016) 0.76
Cancer cells become less deformable and more invasive with activation of β-adrenergic signaling. J Cell Sci (2016) 0.75
Leptin decreases heart rate associated with increased ventricular repolarization via its receptor. Am J Physiol Heart Circ Physiol (2015) 0.75
The Real Role of β-Blockers in Daily Cardiovascular Therapy. Am J Cardiovasc Drugs (2017) 0.75
Beta-Blocker Use Is Associated With Impaired Left Atrial Function in Hypertension. J Am Heart Assoc (2017) 0.75
Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 56.72
Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 41.47
Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 26.95
2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology. Eur Heart J (2013) 9.54
Expansion of cancer care and control in countries of low and middle income: a call to action. Lancet (2010) 6.84
Patient adherence to tuberculosis treatment: a systematic review of qualitative research. PLoS Med (2007) 5.63
Treatment of latent tuberculosis infection in HIV infected persons. Cochrane Database Syst Rev (2010) 4.95
Male circumcision for prevention of heterosexual acquisition of HIV in men. Cochrane Database Syst Rev (2009) 4.86
Non-communicable diseases in sub-Saharan Africa: what we know now. Int J Epidemiol (2011) 4.74
Number of published systematic reviews and global burden of disease: database analysis. BMJ (2003) 4.53
The causes, treatment, and outcome of acute heart failure in 1006 Africans from 9 countries. Arch Intern Med (2012) 3.96
Relation between burden of disease and randomised evidence in sub-Saharan Africa: survey of research. BMJ (2002) 3.78
Cardiovascular disease prevention with a multidrug regimen in the developing world: a cost-effectiveness analysis. Lancet (2006) 3.60
Current status and future prospects of epidemiology and public health training and research in the WHO African region. Int J Epidemiol (2012) 3.60
Achieving the health Millennium Development Goals for South Africa: challenges and priorities. Lancet (2009) 3.35
A theme issue "by, for, and about" Africa. BMJ (2005) 3.32
Interventions for increasing the proportion of health professionals practising in rural and other underserved areas. Cochrane Database Syst Rev (2009) 3.20
Free fatty acid depletion acutely decreases cardiac work and efficiency in cardiomyopathic heart failure. Circulation (2006) 3.12
Research capacity. Enabling the genomic revolution in Africa. Science (2014) 3.05
Errors in the completion of the death notification form. S Afr Med J (2007) 2.94
Defining research to improve health systems. PLoS Med (2010) 2.92
Aetiology and risk factors of peripartum cardiomyopathy: a systematic review. Int J Cardiol (2008) 2.51
Putting evidence into practice: how middle and low income countries "get it together". BMJ (2004) 2.47
Chromosome 9p21 SNPs Associated with Multiple Disease Phenotypes Correlate with ANRIL Expression. PLoS Genet (2010) 2.39
Novel therapeutic concepts: the epidemic of cardiovascular disease in the developing world: global implications. Eur Heart J (2010) 2.34
Should active recruitment of health workers from sub-Saharan Africa be viewed as a crime? Lancet (2008) 2.31
Conducting a meta-ethnography of qualitative literature: lessons learnt. BMC Med Res Methodol (2008) 2.28
Addressing inequalities in research capacity in Africa. BMJ (2005) 2.16
Ischaemic postconditioning protects against reperfusion injury via the SAFE pathway. Cardiovasc Res (2009) 2.14
A review of health behaviour theories: how useful are these for developing interventions to promote long-term medication adherence for TB and HIV/AIDS? BMC Public Health (2007) 2.11
Metabolic mechanisms in heart failure. Circulation (2007) 2.06
A cost-effective strategy for primary prevention of acute rheumatic fever and rheumatic heart disease in children with pharyngitis. S Afr Med J (2013) 2.01
β-Blockers as initial therapy for hypertension. JAMA (2013) 2.00
Epidemiology and etiology of cardiomyopathy in Africa. Circulation (2005) 1.95
Revision of the Jones Criteria for the diagnosis of acute rheumatic fever in the era of Doppler echocardiography: a scientific statement from the American Heart Association. Circulation (2015) 1.95
Nutritional supplements for people being treated for active tuberculosis. Cochrane Database Syst Rev (2008) 1.89
Non-communicable diseases in sub-Saharan Africa: the case for cohort studies. PLoS Med (2010) 1.88
Is primary prevention of rheumatic fever the missing link in the control of rheumatic heart disease in Africa? Circulation (2009) 1.86
Heart failure in sub-saharan Africa: time for action. J Am Coll Cardiol (2007) 1.85
Trimetazidine, a metabolic modulator, has cardiac and extracardiac benefits in idiopathic dilated cardiomyopathy. Circulation (2008) 1.82
Compliance of clinical trial registries with the World Health Organization minimum data set: a survey. Trials (2009) 1.80
Cost-effectiveness analysis of hypertension guidelines in South Africa: absolute risk versus blood pressure level. Circulation (2005) 1.80
Controversies in atrial fibrillation. Lancet (2006) 1.78
Controversies in hypertension. Lancet (2006) 1.78
Families help cure tuberculosis. Lancet (2006) 1.72
Mutations in FAM111B cause hereditary fibrosing poikiloderma with tendon contracture, myopathy, and pulmonary fibrosis. Am J Hum Genet (2013) 1.70
Randomised controlled trials in Africa of HIV and AIDS: descriptive study and spatial distribution. BMJ (2005) 1.68
Incidence and characteristics of newly diagnosed rheumatic heart disease in urban African adults: insights from the heart of Soweto study. Eur Heart J (2009) 1.65
A decade of tobacco control: the South African case of politics, health policy, health promotion and behaviour change. S Afr Med J (2013) 1.60
Towards a uniform plan for the control of rheumatic fever and rheumatic heart disease in Africa--the Awareness Surveillance Advocacy Prevention (A.S.A.P.) Programme. S Afr Med J (2006) 1.59
Primary prevention of acute rheumatic fever and rheumatic heart disease with penicillin in South African children with pharyngitis: a cost-effectiveness analysis. Circ Cardiovasc Qual Outcomes (2013) 1.59
Position statement of the World Heart Federation on the prevention and control of rheumatic heart disease. Nat Rev Cardiol (2013) 1.59
Epidemiology of heart failure in sub-Saharan Africa. Expert Rev Cardiovasc Ther (2009) 1.59
Beta-blockers for hypertension. Cochrane Database Syst Rev (2012) 1.56
The Drakensberg declaration on the control of rheumatic fever and rheumatic heart disease in Africa. S Afr Med J (2006) 1.53
Estimates of global, regional, and national incidence, prevalence, and mortality of HIV, 1980-2015: the Global Burden of Disease Study 2015. Lancet HIV (2016) 1.51
Promoting adherence to tuberculosis treatment. Bull World Health Organ (2007) 1.51
Cardiovascular disease in sub-Saharan Africa. Circulation (2005) 1.50
Genotype at a promoter polymorphism of the interleukin-6 gene is associated with baseline levels of plasma C-reactive protein. Cardiovasc Res (2002) 1.50
Identification of a novel role for sphingolipid signaling in TNF alpha and ischemic preconditioning mediated cardioprotection. J Mol Cell Cardiol (2002) 1.49
Material incentives and enablers in the management of tuberculosis. Cochrane Database Syst Rev (2012) 1.47
Antibiotics for the primary prevention of acute rheumatic fever: a meta-analysis. BMC Cardiovasc Disord (2005) 1.46
Evidence-based public health: what does it offer developing countries? J Public Health (Oxf) (2005) 1.46
Effect of losartan versus candesartan on uric acid, renal function, and fibrinogen in patients with hypertension and hyperuricemia associated with diuretics. Am J Hypertens (2006) 1.46
Rapid increases in overweight and obesity among South African adolescents: comparison of data from the South African National Youth Risk Behaviour Survey in 2002 and 2008. Am J Public Health (2011) 1.42
Prevalence of myocarditis and cardiotropic virus infection in Africans with HIV-associated cardiomyopathy, idiopathic dilated cardiomyopathy and heart transplant recipients: a pilot study: cardiovascular topic. Cardiovasc J Afr (2013) 1.41
South Africa's experience of the closure of the cellulose sulphate microbicide trial. PLoS Med (2007) 1.40
Motion-guided segmentation for cine DENSE MRI. Med Image Anal (2008) 1.40
Genetic depletion of cardiac myocyte STAT-3 abolishes classical preconditioning. Cardiovasc Res (2004) 1.34
Recent advances in the epidemiology, pathogenesis and prognosis of acute heart failure and cardiomyopathy in Africa. Heart (2013) 1.30
The 10 'Best Buys' to combat heart disease, diabetes and stroke in Africa. Heart (2013) 1.29
How strong is the evidence for use of beta-blockers as first-line therapy for hypertension? Systematic review and meta-analysis. J Hypertens (2006) 1.28
Cardiac manifestations of HIV infection: an African perspective. Nat Clin Pract Cardiovasc Med (2008) 1.27
Frequency and clinical genetics of familial dilated cardiomyopathy in Cape Town: implications for the evaluation of patients with unexplained cardiomyopathy. S Afr Med J (2011) 1.27
A modern approach to tuberculous pericarditis. Prog Cardiovasc Dis (2007) 1.26
Patient education and counselling for promoting adherence to treatment for tuberculosis. Cochrane Database Syst Rev (2012) 1.26
A new mutation, R563Q, of the beta subunit of the epithelial sodium channel associated with low-renin, low-aldosterone hypertension. J Hypertens (2003) 1.23
Dual activation of STAT-3 and Akt is required during the trigger phase of ischaemic preconditioning. Cardiovasc Res (2008) 1.21
Clinical features, survival experience, and profile of plakophylin-2 gene mutations in participants of the arrhythmogenic right ventricular cardiomyopathy registry of South Africa. Heart Rhythm (2009) 1.20
Clinical characteristics and outcomes of familial and idiopathic dilated cardiomyopathy in Cape Town: a comparative study of 120 cases followed up over 14 years. S Afr Med J (2011) 1.20
Rationale and design of a Global Rheumatic Heart Disease Registry: the REMEDY study. Am Heart J (2012) 1.20
Strengthening research capacity. Lancet (2002) 1.18
STK39 polymorphisms and blood pressure: an association study in British Caucasians and assessment of cis-acting influences on gene expression. BMC Med Genet (2009) 1.17
Echocardiographic screening for subclinical rheumatic heart disease remains a research tool pending studies of impact on prognosis. Curr Cardiol Rep (2013) 1.16
Cardiac involvement in HIV-infected people living in Africa: a review. Cardiovasc J S Afr (2003) 1.15
Apolipoprotein(a) genetic sequence variants associated with systemic atherosclerosis and coronary atherosclerotic burden but not with venous thromboembolism. J Am Coll Cardiol (2012) 1.14
Group A streptococcal vaccines: paving a path for accelerated development. Vaccine (2013) 1.12
Association between common polymorphisms of the proopiomelanocortin gene and body fat distribution: a family study. Diabetes (2005) 1.11